Evidence map›Paper›PMID 30336778›Full record

ArticleBMC medicine2018

Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic.

Kaiyuan Sun, Qian Zhang, Ana Pastore-Piontti, Matteo Chinazzi, Dina Mistry, Natalie E Dean, Diana Patricia Rojas, Stefano Merler, Piero Poletti, Luca Rossi and 3 more

Abstract readHistorical Article
In one paragraph

Article in BMC medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kaiyuan SunLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, 02115, USA.
Qian ZhangLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, 02115, USA.
Ana Pastore-PionttiLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, 02115, USA.
Matteo ChinazziLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, 02115, USA.
Dina MistryLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, 02115, USA.
Natalie E DeanDepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, 32611, USA.
Diana Patricia RojasDepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, 32611, USA.
Stefano MerlerBruno Kessler Foundation, 38123, Trento, Italy.
Piero PolettiBruno Kessler Foundation, 38123, Trento, Italy.
Luca RossiInstitute for Scientific Interchange Foundation, 10126, Turin, Italy.
M Elizabeth HalloranVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, 98109, USA.
Ira M LonginiDepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, 32611, USA.
Alessandro VespignaniLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, 02115, USA. a.vespignani@neu.edu.

Funding

Understanding Transmission with Integrated Genetic and Epidemiologic InferenceU54GM111274 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2014 to 2018
$12.5M
Methods for Reducing Spatial Uncertainty and Bias in Disease SurveillanceR01AI102939 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LESSLER, JUSTIN · 2013 to 2017
$4.6M
NIAID NIH HHS R01 AI102939NIGMS NIH HHS U54 GM111274NIH HHS R01 AI102939-05
6 · The paper itself

Abstract

backgroundLocal mosquito-borne Zika virus (ZIKV) transmission has been reported in two counties in the contiguous United States (US), prompting the issuance of travel, prevention, and testing guidance across the contiguous US. Large uncertainty, however, surrounds the quantification of the actual risk of ZIKV introduction and autochthonous transmission across different areas of the US.

methodsWe present a framework for the projection of ZIKV autochthonous transmission in the contiguous US during the 2015-2016 epidemic using a data-driven stochastic and spatial epidemic model accounting for seasonal, environmental, and detailed population data. The model generates an ensemble of travel-related case counts and simulates their potential to have triggered local transmission at the individual level in the 2015-2016 ZIKV epidemic.

resultsWe estimate the risk of ZIKV introduction and local transmission at the county level and at the 0.025° × 0.025° cell level across the contiguous US. We provide a risk measure based on the probability of observing local transmission in a specific location during a ZIKV epidemic modeled after the epidemic observed during the years 2015-2016. The high spatial and temporal resolution of the model allows us to generate statistical estimates of the number of ZIKV introductions leading to local transmission in each location. We find that the risk was spatially heterogeneously distributed and concentrated in a few specific areas that account for less than 1% of the contiguous US population. Locations in Texas and Florida that have actually experienced local ZIKV transmission were among the places at highest risk according to our results. We also provide an analysis of the key determinants for local transmission and identify the key introduction routes and their contributions to ZIKV transmission in the contiguous US.

conclusionsThis framework provides quantitative risk estimates, fully captures the stochasticity of ZIKV introduction events, and is not biased by the under-ascertainment of cases due to asymptomatic cases. It provides general information on key risk determinants and data with potential uses in defining public health recommendations and guidance about ZIKV risk in the US.

Indexed as

AnimalsEpidemicsHistory, 21st CenturyHumansPatient-Specific ModelingPublic HealthRisk AssessmentUnited StatesZika Virus InfectionComputational modelingRisk assessmentZika virus

Identifiers

PMID30336778
PMCPMC6194624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.